Literature DB >> 29631981

Role of Androgens in Female Genitourinary Tissue Structure and Function: Implications in the Genitourinary Syndrome of Menopause.

Abdulmaged M Traish1, Linda Vignozzi2, James A Simon3, Irwin Goldstein4, Noel N Kim5.   

Abstract

INTRODUCTION: Genitourinary conditions in women increase in prevalence with age. Androgens are prerequisite hormones of estrogen biosynthesis, are produced in larger amounts than estrogens in women, and decrease throughout adulthood. However, research and treatment for genitourinary complaints have traditionally focused on estrogens to the exclusion of other potential hormonal influences. AIM: To summarize and evaluate the evidence that androgens are important for maintaining genitourinary health in women and that lack of androgenic activity can contribute to the development of symptoms of the genitourinary syndrome of menopause.
METHODS: The role of androgens in the pathophysiology, diagnosis, and treatment of genitourinary syndrome of menopause was discussed by an international and multidisciplinary panel during a consensus conference organized by the International Society for the Study of Women's Sexual Health. A subgroup further examined publications from the PubMed database, giving preference to clinical studies or to basic science studies in human tissues. MAIN OUTCOME MEASURES: Expert opinion evaluating trophic and functional effects of androgens, their differences from estrogenic effects, and regulation of androgen and estrogen receptor expression in female genitourinary tissues.
RESULTS: Androgen receptors have been detected throughout the genitourinary system using immunohistochemical, western blot, ligand binding, and gene expression analyses. Lower circulating testosterone and estradiol concentrations and various genitourinary conditions have been associated with differential expression of androgen and estrogen receptors. Supplementation of androgen and/or estrogen in postmenopausal women (local administration) or in ovariectomized animals (systemic administration) induces tissue-specific responses that include changes in androgen and estrogen receptor expression, cell growth, mucin production, collagen turnover, increased perfusion, and neurotransmitter synthesis.
CONCLUSION: Androgens contribute to the maintenance of genitourinary tissue structure and function. The effects of androgens can be distinct from those of estrogens or can complement estrogenic action. Androgen-mediated processes might be involved in the full or partial resolution of genitourinary syndrome of menopause symptoms in women. Traish AM, Vignozzi L, Simon JA, et al. Role of Androgens in Female Genitourinary Tissue Structure and Function: Implications in the Genitourinary Syndrome of Menopause. Sex Med Rev 2018;6:558-571.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Androgen Receptor; Dihydrotestosterone; Estradiol; Estrogen Receptor; Testosterone; Vulvovaginal Atrophy

Mesh:

Substances:

Year:  2018        PMID: 29631981     DOI: 10.1016/j.sxmr.2018.03.005

Source DB:  PubMed          Journal:  Sex Med Rev        ISSN: 2050-0521


  17 in total

Review 1.  Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications.

Authors:  Zachary J Solomon; Jorge Rivera Mirabal; Daniel J Mazur; Taylor P Kohn; Larry I Lipshultz; Alexander W Pastuszak
Journal:  Sex Med Rev       Date:  2018-11-30

Review 2.  Impact of Immune System Activation and Vascular Impairment on Male and Female Sexual Dysfunction.

Authors:  Fabiano B Calmasini; Nicole Klee; R Clinton Webb; Fernanda Priviero
Journal:  Sex Med Rev       Date:  2019-07-17

3.  Nomegestrol acetate/17beta-estradiol does not negatively alter the vascular resistance of clitoral arteries: a prospective, exploratory study.

Authors:  Irene Scavello; Elisa Maseroli; Vincenza Di Stasi; Sarah Cipriani; Nunzia Verde; Angela Magini; Mario Maggi; Linda Vignozzi
Journal:  Int J Impot Res       Date:  2019-07-01       Impact factor: 2.896

Review 4.  Practical Treatment Considerations in the Management of Genitourinary Syndrome of Menopause.

Authors:  Risa Kagan; Susan Kellogg-Spadt; Sharon J Parish
Journal:  Drugs Aging       Date:  2019-10       Impact factor: 3.923

Review 5.  Sexual Health in Menopause.

Authors:  Irene Scavello; Elisa Maseroli; Vincenza Di Stasi; Linda Vignozzi
Journal:  Medicina (Kaunas)       Date:  2019-09-02       Impact factor: 2.430

6.  Effects of ospemifene on genitourinary health assessed by prospective vulvar-vestibular photography and vaginal/vulvar health indices.

Authors:  Irwin Goldstein; James A Simon; Andrew M Kaunitz; Corrado Altomare; Yuki Yoshida; Julie Zhu; Sam Schaffer; Graziella Soulban
Journal:  Menopause       Date:  2019-09       Impact factor: 2.953

7.  Changes of androgens levels in menopausal women.

Authors:  Maria Brzozowska; Andrzej Lewiński
Journal:  Prz Menopauzalny       Date:  2021-01-07

Review 8.  Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women.

Authors:  Rossella E Nappi; Ellis Martini; Laura Cucinella; Silvia Martella; Lara Tiranini; Alessandra Inzoli; Emanuela Brambilla; David Bosoni; Chiara Cassani; Barbara Gardella
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-21       Impact factor: 5.555

9.  Position statement by Experts of the Polish Menopause and Andropause Society, and the Polish Society of Aesthetic and Reconstructive Gynaecology on the medicinal product Intrarosa®.

Authors:  Małgorzata Bińkowska; Tomasz Paszkowski; Skrzypulec-Plinta Violetta; Maciej Wilczak; Wojciech Zgliczyński
Journal:  Prz Menopauzalny       Date:  2019-12-20

10.  Prolonged use of finasteride-induced gonadal sex steroids alterations, DNA damage and menstrual bleeding in women.

Authors:  Gadah Albasher; May Bin-Jumah; Saleh Alfarraj; Fatimah Al-Otibi; Nouf K Al-Sultan; Saud Alarifi; Saad Alkahtani; Nahed S Alharthi; Wedad S Al-Qahtani
Journal:  Biosci Rep       Date:  2020-02-28       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.